+44 203 371 1100
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 07-Sep-2023 | New Bond | - | - | US375558CA99 |
| Gilead Sciences, Inc. today announced that it has issued USD 1MMM, 5.550% Fixed bond due 15-Oct-2053. | ||||
| 07-Sep-2023 | New Bond | - | - | US375558BZ59 |
| Gilead Sciences, Inc. today announced that it has issued USD 1MMM, 5.250% Fixed bond due 15-Oct-2033. | ||||
| 21-Jul-2023 | Final Maturity | - | - | US375558BL63 |
| Gilead Sciences, Inc. today announced that the bond has reached its full maturity for USD 750MM, 2.500% Fixed rate bond due 01-Sep-2023. | ||||
| 22-Feb-2023 | Acquisition | Acquired Name | Tmunity Therapeutics, Inc. | - |
| Gilead Sciences, Inc. today announces that it has acquired Tmunity Therapeutics, Inc.. | ||||
| 09-May-2023 | Propose Acquisition | Target Name | XinThera, Inc. | - |
| Gilead Sciences, Inc. today announced that it intends to acquire XinThera, Inc.. | ||||
All of the financial data available on this page is sourced from FactEntry.